Details for New Drug Application (NDA): 204796
✉ Email this page to a colleague
NDA 204796 describes CAPREOMYCIN SULFATE, which is a drug marketed by Hisun Pharm Hangzhou and Norvium Bioscience and is included in two NDAs. Additional details are available on the CAPREOMYCIN SULFATE profile page.
The generic ingredient in CAPREOMYCIN SULFATE is capreomycin sulfate. There are three drug master file entries for this compound. Additional details are available on the capreomycin sulfate profile page.
The generic ingredient in CAPREOMYCIN SULFATE is capreomycin sulfate. There are three drug master file entries for this compound. Additional details are available on the capreomycin sulfate profile page.
Summary for 204796
| Tradename: | CAPREOMYCIN SULFATE |
| Applicant: | Hisun Pharm Hangzhou |
| Ingredient: | capreomycin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 204796
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Oct 18, 2018 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
